Skip to main content

Maxalt Melt 10mg Wafers

What are Maxalt Melt Wafers?

Maxalt Melt 10mg Wafers contain the active ingredient rizatriptan, which is classed as a “5HT1 agonist”; this group of medicines are also known as “triptans”. Rizatriptan is available for the treatment of headaches associated with migraines. It treats the symptoms effectively, but it does not prevent migraines from happening in advance, and it shouldn’t be taken preventatively.

Start an online consultation with one of our UK-registered GPs
Our GP may advise, prescribe or recommend further tests
Receive certified genuine medication by your chosen delivery method
Maxalt Melt (Rizatriptan) 10mg 3 Wafers Maxalt Melt (Rizatriptan) 10mg 3 Wafers £5.57 per tablet Prescription only Select

How to use Maxalt Melt Wafers

It’s important to read the enclosed leaflet carefully before using Maxalt Melt Wafers.

This medicine comes in a small sachet, the contents of which (the “wafer”) are placed onto the tongue, where the medicine dissolves quickly and is swallowed with the saliva. This means that it’s very useful if you have experienced nausea or vomiting, or where a glass of water would not be available.

g wafer as soon as possible after your migraine headache starts. However it can still be effective if you take it at a later stage of the headache. It doesn’t matter if you take it with or without food.

If you have another headache later, a second dose can be taken; but you should not take more than one tablet per migraine attack. The second dose should not be taken within 2 hours of the first tablet, and don’t take more than 2 doses (20mg) in any 24 hour period.

Is Maxalt Melt suitable for me?

There are some situations where Maxalt Melt, like all medicines, should be used with caution or would not be recommended, for example in people aged under 18 or over 65; people who have now (or who have had in the past) heart problems including stroke, transient ischaemic attack, angina, heart attack, or high blood pressure; people with liver or kidney problems, and people who are allergic to any of the active or inactive ingredients.

Some people with risk factors for heart disease may not be suitable for Maxalt Melt treatment, for example people with a strong family history of heart disease, and those who are heavy smokers or who use nicotine replacement therapies, especially when they are women after the menopause or men over 40.

During your consultation, it is important to tell us if you are taking any other medicines, either from your doctor or purchased from a pharmacy without a prescription. Maxalt Melt can cause problems if taken with certain other medicines, including some other medicines for migraines (methysergide, ergotamine, other triptans), some antidepressant medicines (MAOI’s, and also SSRI’s and SNRI’s, which may also be prescribed for anxiety), or St John’s Wort supplements.

It is important to mention during the consultation if you are pregnant or think you might be pregnant, or are breast-feeding or planning to breast-feed.

If it doesn’t work for you, tell the doctor because a different treatment might be better.

It’s very important to give a full picture of your general health in the consultation, to make sure the doctor has all the information required to assess the suitability of Maxalt Melt for you.

Maxalt Melt side effects

Like all medicines, Maxalt Melt can cause side effects, although not everybody gets them.

Side effects that are considered to be common include dizziness, tiredness, headaches, muscle tremors, palpitations, hot flushes, sweating, throat discomfort, dry mouth, nausea, vomiting, feelings of heaviness, and pains in the chest or stomach.

Other less common side effects can include insomnia, vertigo, taste disturbances, raised blood pressure, indigestion, skin rashes, and thirst. If you experience any persistent or troublesome side effects you should stop using Maxalt Melt and talk to your doctor.

For a full list of potential side effects and other important information, please read the patient information leaflet provided in the pack before starting any course of treatment. The leaflet can also be viewed online here: